Poland Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Poland Pharmaceuticals and Healthcare Report

Poland Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Poland Pharmaceuticals and Healthcare Report
Published Oct 22, 2016
87 pages — Published Oct 22, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

An opinion poll run by the Polish Public Opinion Research Centre (CBOS), published on August - ----, revealed that, while two thirds of respondents had a positive opinion on the competence of doctors, just - were satisfied with their ability to access specialist medical care, and over three quarters of Poles are dissatisfied with the health service overall. In August ----, the Ministry of Health published a new list of reimbursed drugs including medicines for the treatment of advanced ovarian cancer and Parkinson s disease, entering force on September - ----. ...An opinion poll run by the Polish Public Opinion Research Centre (CBOS), published on August - ----, revealed that, while two thirds of respondents had a positive opinion on the competence of doctors, just - were satisfied with their ability to access specialist medical care, and over three quarters of Poles are dissatisfied with the health service overall. In August ----, the Ministry of Health published a new list of reimbursed drugs including medicines for the treatment of advanced ovarian cancer and Parkinson s disease, entering force on September - ----. In July ----, the Minster of Health announced the polish government s long-awaited healthcare reform plan, a key part of the Law and Justice (PiS) party s election campaign in October ----. In June ----, Minister of Health Konstanty Radziwill reiterated his ambition to increase government healthcare expenditure to - of GDP, up from the current -.- . In June ----, the Polish Association of Medical Tourism published data that showed the market value of medical tourism in the country had doubled since ---- to a value of EUR---mn and that patients travelling from abroad each spend up to EUR--,--- on medical procedures in private clinics.

...BMI View: Poland s pharmaceutical market growth will continue to gain momentum over our forecast period. Drug sales will be driven by Polish consumers benefitting from real wage increases and rising employment. ...Drug sales will be driven by Polish consumers benefitting from real wage increases and rising employment. Furthermore, the government s plans implement a tax-financed healthcare system in ----, will see dramatic improvements for both the Polish population and for multinational pharmaceutical companies. A positive economic outlook along with the National Health Fund s (NFZ s) ---- financial plan for a sustained rise in pharmaceutical spending reaffirms our view on Poland s position as a leading market in the Central and Eastern Europe (CEE) region. ...Furthermore, the government s plans implement a tax-financed healthcare system in ----, will see dramatic improvements for both the Polish population and for multinational pharmaceutical companies. A positive economic outlook along with the National Health Fund s (NFZ s) ---- financial plan for a sustained rise in pharmaceutical spending reaffirms our view on Poland s position as a leading market in the Central and Eastern Europe (CEE) region.

...Poland has a Risk/Reward Index (RRI) score of --.- out of --- for Q---, unchanged from last quarter, making it the second most attractive pharmaceutical market in Central and Eastern Europe (CEE), just below the Czech Republic (--.-). Poland has the second highest pharmaceutical market expenditure (score of --.- out of --.-) in CEE, behind Russia. ...

  
Source:
Document ID
1748-2100
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Poland Pharmaceuticals and Healthcare Report" Oct 22, 2016. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Poland-Pharmaceuticals-and-Healthcare-Report-2026-296>
  
APA:
Business Monitor International - Industry Reports. (2016). Poland Pharmaceuticals and Healthcare Report Oct 22, 2016. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Poland-Pharmaceuticals-and-Healthcare-Report-2026-296>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.